RBC Raises Price Target on Bausch Health to $10 From $9
RBC has increased its price target for Bausch Health Companies Inc. to $10 from $9 while maintaining a Sector Perform rating.
Stocks · News reference
Huntington Ingalls, Crocs, Carvana, Insmed And Other Big Stocks Moving Higher On Thursday
Stocks rallied on strong earnings and raised guidance, led by Huntington Ingalls, Porch, Teladoc and Crocs, despite the Dow falling 150 points.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Bausch Health Announces Third Quarter 2026 Financial Results and Raises Guidance
Bausch Health reported strong third-quarter 2026 financial results, including a 10% increase in consolidated revenues and an increase in adjusted earnings per share, leading the company to raise its financial guidance.
Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027
Bausch Health plans to redeem approximately $643 million of its outstanding 8.500% senior notes due in 2027 using cash on hand.
Churchill Downs Incorporated Announces Relocation of Rosie's Game Room in Virginia
Churchill Downs Incorporated plans to relocate its Rosie's Game Room facility in Henry County, Virginia, to a new, larger venue near Martinsville Speedway.
Churchill Downs Incorporated Appoints Michael Tucker to Board of Directors
Churchill Downs Incorporated has appointed Michael Tucker, founder of Orvieto Partners, L.P., to its Board of Directors.
Churchill Downs and NYRA Expand Thoroughbred Championship Series for 2027
Churchill Downs Incorporated and The New York Racing Association are expanding their Thoroughbred Championship Series in 2027 to include a new Oaks Division for three-year-old fillies.